ZEB2 and neoplasm: In NSCLC tissues and cell lines, E2F1 is notably upregulated and controls ZEB2 expression via an E2F1 binding site on the ZEB2 promoter, ultimately driving EMT and enhancing tumor invasion and metastasis (91, 92).